Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Memira
Mandate

Vinge advises on the sale of Memira

July 08, 2019 M&A

Vinge has advised Patricia Industries AB, part of Investor AB, and other shareholders in Memira Holding AB in connection with the sale of the company to the Dutch company Bergman Clinics BV.

With 47 clinics, Memira is the Nordic Region’s leading chain providing sight correction operations and one of the leading actors in the world in relation to change of lenses.

The transaction is subject to customary closing conditions.

Vinge’s team primarily consisted of Johan Winnerblad, Kristina Ekberg, Karl Klackenberg, Martin Cronsioe, Milad Kamali, Daniel Wendelsson, Maria Schultzberg, Henrik Wastensson and Sofie Sundin. 

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025